Loading...

OTC Markets

Totals

Securities

12,348

Dollar Vol

$2.6B

Share Vol

3.5B

Trades

312,468

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

Market Activity
Stock
XSNX
Company Profile

XSNX
NOVACCESS GLOBAL INC.

Common Stock

NOVACCESS GLOBAL INC.

8584 E. Washington Street #127

Chagrin Falls, OH 44023

Principal Executive Offices:

8584 E. Washington Street

No. 127

Chagrin Falls, OH 44023

www.novaccessglobal.com

(213) 642-9268

info@novaccessglobal.com

Last Verified 06/2024

Business Description

NovAccess Global Inc. is a biopharmaceutical company focused on the development and commercialization of novel immunotherapies to treat brain tumor patients in the United States with plans to expand globally. We are experts in cutting-edge research involving the use of a patient's own immune system to fight cancer. Through our advisory board we have experience successfully executing clinical trials, bringing products to market and increasing the market size of products. Our scientists are well versed in immunology, stem cell biology, neuroscience, molecular biology, imaging, small molecule development and gene therapy as well as other technical assays required for protein and genetic analysis ...

Financial Reporting

Reporting Status

U.S. Reporting: SEC Reporting

Audited Financials

Audited

Latest Report

07/26/2024 8K Report

CIK

0001039466

Fiscal Year End

9/30

Company Officers & Contacts

Dwain Irvin

CEO

Dawn Frazer

Other

Board of Directors

John Cassarini

Chairman, Independent Director, Audit Committee Member

Jason Anderson

Independent Director, Audit Committee Member

Dwain Irvin

CEO

Other Company Insiders

Unknown Unknown

Innovest Global Inc

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.

Service Providers

Accounting/Auditing Firm

M&K CPAS, PLLC

363 N. Sam Houston Parkway E.

Suite 650

Houston, TX 77060

Investor Relations/Marketing/Communications

Darrow Associates - Austin, Texas (USA)

3616 Far West Boulevard,

Suite 117-280

Austin, TX 78731

Securities Counsel

Kohrman Jackson & Krantz PLL

1375 East 9th Street, One Cleveland Center,

29th Floor

Cleveland, OH 44114-1793

Profile Data

SIC - Industry Classification

2834 - Pharmaceutical preparations

Incorporation Information

CO, US, 1997

Employees

2 as of 01/18/2024

Shell

Products and Services

NovAccess Global Inc. is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States and eventually Globally.

Company Facilities

NovAccess global operates remotely, and utilizes outsourced laboratories at qualified facilities for its research.

Company Notes

Formerly=XsunX, Inc. until 8-2020

Note=9-30-04 company is in the development stage

Formerly=Sun River Mining, Inc. until 10-03